Viewing Study NCT00683059


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-30 @ 11:38 PM
Study NCT ID: NCT00683059
Status: COMPLETED
Last Update Posted: 2016-10-17
First Post: 2008-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Agent Abraxane as Second Line Therapy in Bladder Cancer
Sponsor: Sunnybrook Health Sciences Centre
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module